Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000884614 | SCV001028005 | benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV001007615 | SCV001167302 | likely benign | Interstitial lung disease due to ABCA3 deficiency | 2019-11-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001007615 | SCV001280595 | uncertain significance | Interstitial lung disease due to ABCA3 deficiency | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000884614 | SCV002563296 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | ABCA3: BP4, BP7 |
Ambry Genetics | RCV002372509 | SCV002624336 | likely benign | Hereditary pulmonary alveolar proteinosis | 2017-03-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |